These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6169212)

  • 1. [Foetomaternal transfusions after amniocentesis in early pregnancy - evaluation of 1,000 cases (author's transl)].
    Schmidt W; Gabelmann J; Boos R; Garoff L; Kubli K
    Z Geburtshilfe Perinatol; 1980 Oct; 184(5):359-65. PubMed ID: 6169212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [On the feto-maternal transfusion of red blood cells during transplacental and para-placental genetic amniocenteses (author's transl)].
    Zach HP; Zahn V; Herzog B; Stühmer M
    Geburtshilfe Frauenheilkd; 1979 May; 39(5):378-83. PubMed ID: 456859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Feto-maternal microtranfusion after amniocentesis in the 2nd trimenon (author's transl)].
    Schultze-Mosgau H; Lehmann F
    Med Klin; 1976 Jan; 71(2):60-2. PubMed ID: 1246217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fetomaternal transfusions in early pregnancy].
    du Bois A; Rasenack R; Siebers JW; Geyer H; Quaas L
    Z Geburtshilfe Perinatol; 1991; 195(2):71-5. PubMed ID: 1716034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rh sensitization after genetic amniocentesis.
    Hill LM; Platt LD; Kellogg B
    Obstet Gynecol; 1980 Oct; 56(4):459-61. PubMed ID: 6775257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal-maternal bleeding associated with genetic amniocentesis.
    Mennuti MT; Brummond W; Crombleholme WR; Schwarz RH; Arvan DA
    Obstet Gynecol; 1980 Jan; 55(1):48-54. PubMed ID: 6153239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risks of fetomaternal hemorrhage resulting from amniocentesis with and without ultrasound placental localization.
    Harrison R; Campbell S; Craft I
    Obstet Gynecol; 1975 Oct; 46(4):389-91. PubMed ID: 1165872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alpha fetoprotein and HbF cells in the maternal blood and their modification through amniocentesis].
    Maas DH; Hoppe B; Weitzel HK
    Fortschr Med; 1979 Jun; 97(21):981-6. PubMed ID: 86491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic mid trimester amniocentesis: how safe?
    Seeds JW
    Am J Obstet Gynecol; 2004 Aug; 191(2):607-15. PubMed ID: 15343248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gel agglutination test--a new test system for semiquantitative detection of feto-maternal transfusion in Rhesus incompatibility].
    David M; Stelzer A; Wittmann G; Dudenhausen JW; Salama A
    Z Geburtshilfe Neonatol; 1999; 203(6):241-5. PubMed ID: 10612196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplacental fetal hemorrhage after amniocentesis.
    Bowman JM; Pollock JM
    Obstet Gynecol; 1985 Dec; 66(6):749-54. PubMed ID: 3934608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of haemoglobin F detection by the acid elution test, flow cytometry and high-performance liquid chromatography in maternal blood samples analysed for fetomaternal haemorrhage.
    Chambers E; Davies L; Evans S; Birchall J; Kumpel B
    Transfus Med; 2012 Jun; 22(3):199-204. PubMed ID: 22429383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fetomaternal transfusion in abortion and pregnancy interruptions and Rh-prevention].
    Radzuweit H; Krüger B
    Zentralbl Gynakol; 1975; 97(22):1367-74. PubMed ID: 812290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetomaternal hemorrhage after midtrimester genetic amniocentesis at King Chulalongkorn Memorial Hospital.
    Tannirandorn Y; Romayanan O
    J Med Assoc Thai; 1999 Nov; 82(11):1089-93. PubMed ID: 10659542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rh isoimmunization related to amniocentesis.
    Murray JC; Karp LE; Williamson RA; Cheng EY; Luthy DA
    Am J Med Genet; 1983 Dec; 16(4):527-34. PubMed ID: 6419606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Frequency and importance of fetomaternal hemorrhages through early amniocentesis].
    Sender A; Pinon F; Maigret P; Henrion R; Chavinie J; Van Nifterik J
    Rev Fr Transfus Immunohematol; 1975 Dec; 18(4):373-84. PubMed ID: 819979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The assessment of feto-maternal hemorrhage in an artificial model using anti-D and anti-fetal hemoglobin antibody by flow cytometry.
    Pourazar A; Homayouni V; Rezaei A; Andalib A; Oreizi F
    Iran Biomed J; 2008 Jan; 12(1):43-8. PubMed ID: 18392094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal-maternal hemorrhage after amniocentesis: incidence, degree and ramifications.
    Goldstein AI; Pezzlo F
    Int J Gynaecol Obstet; 1978-1979; 16(3):187-9. PubMed ID: 33076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood contamination of amniotic fluid after amniocentesis in relation to placental location.
    Giorlandino C; Gambuzza G; D'Alessio P; Santoro ML; Gentili P; Vizzone A
    Prenat Diagn; 1996 Feb; 16(2):180-2. PubMed ID: 8650131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation of fetomaternal haemorrhage and F cells in unusual maternal blood samples by flow cytometry using anti-D and anti-HbF.
    Kumpel BM; MacDonald AP; Bishop DR; Yates AF; Lee E
    Transfus Med; 2013 Jun; 23(3):175-86. PubMed ID: 23578132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.